Curis
CRIS
#10228
Rank
NZ$25.76 M
Marketcap
NZ$1.99
Share price
-1.71%
Change (1 day)
-65.23%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.36. In 2024 the company made an earnings per share (EPS) of NZ-$12.18 an increase over its 2023 EPS that were of NZ-$15.65.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-47.62%
2024NZ-$12.18-22.15%
2023NZ-$15.65-26.17%
2022NZ-$21.2022.3%
2021NZ-$17.33-25.37%
2020NZ-$23.22-30.93%
2019NZ-$33.62-2.02%
2018NZ-$34.32
2016NZ-$77.99-10%
2015NZ-$86.66138.1%
2014NZ-$36.4040%
2013NZ-$26.00-25%
2012NZ-$34.6666.67%
2011NZ-$20.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
NZ$4.12-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.44-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.62-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.86-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.98-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.15-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.48 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA